Clarivate Analytics launches Cortellis Digital Health Intelligence, a first-of-its-kind solution covering the global digital health ecosystem

(14 Aug 2019)  Clarivate Analytics plc, a global leader in providing trusted insights and analytics to accelerate the pace of innovation, has expanded its industry-leading life science intelligence offerings with the launch of Cortellis Digital Health Intelligence™. This new, first-of-its-kind solution will help drug, device and technology developers navigate the dynamic digital health landscape with intelligence focused on virtual, consumer-centric solutions (including both hardware and software) that enable health management or patient care in real-life settings.

The launch of Cortellis Digital Health Intelligence comes at a time when the industry is experiencing growth in digital health and patients are actively integrating technologies into their healthcare. In the US alone, 64% of patients have adopted a digital device (including mobile apps) to manage their health, and 62% of healthcare systems and hospitals use digital health devices in their clinical care programs.

Globally, more than 800 clinical trials adopted a smartphone, wearable, and/or monitoring device in their protocol, and this number is expected to increase significantly. These market dynamics demonstrate the need for better information and more robust analytics on digital technologies used in drug/device development and patient-centric care.

Cortellis Digital Health Intelligence includes new alliances and deals information, independent health app reviews, digital health news and the latest discovery, development and commercialisation trends. The solution delivers actionable insights through a structured database that is updated daily and indexed by digital health topic, enabling users to easily browse, filter, export and compare data.

Cortellis Digital Health Intelligence can also be integrated with the broader suite of Cortellis life science intelligence solutions. This results in users gaining seamless access to drug pipeline information, company profiles and trial data and giving them a comprehensive foundation for analysis and decision-making at a company, portfolio, therapeutic area or individual asset level. Consulting services are available to support customised analytics and reporting needs, including identifying clinically-validated and effective digital health solutions.

The initial Cortellis Digital Health Intelligence offering is comprised of expertly curated data encompassing nearly 6,000 relevant press releases, over 4,000 digital health app reviews and more than 3,000 digital health deals. These information sets will rapidly increase in volume, as well as expand to encompass a broader view of the digital health landscape that includes patents, company profiles, device records and digital trial protocols. The solution is powered by Cortellis Cloud, an integrated, scalable technology platform that serves as a single point of access to Cortellis content.

The original press release is here.